Brind.

CEO Dan O'Brien commented on R&D support revenue.

1 report, 0 independent Updated Jul 2

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

SpeculativeNo independent reporting found

Who's involved

What this event is mainly about

Dan O'Brien Company

Keep exploring

The entities involved

Dan O'Brien
researcher

Nothing else this week.
Company
Direct Mail Division of FSSI
- A company is conducting clinical trials and seeking drug approval for the U.S. market under the FDA.Mon 13:17
- A partnership with BARDA has accelerated the development of SCY-247 for the company.Mon 13:17

Coverage

Newest first; wire copies grouped

Jul 2Unknown outlet